Positron emission tomography in the early diagnosis of Huntington's disease
- 1 July 1986
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 36 (7), 888
- https://doi.org/10.1212/wnl.36.7.888
Abstract
We studied 10 patients with early Huntington's disease and 7 normal age-matched controls with positron emission tomography (PET) using fluorodeoxyglucose. Subjects had little or no caudate nucleus atrophy and had not received any medications. The results demonstrated that hypometabolism of glucose preceded tissue loss. Furthermore, patients with minimal neurologic or psychiatric symptoms and no obvious CT changes may be differentiated from normal persons with high accuracy by PET. PET is helpful in the early diagnosis of Huntington's disease irrespective of the mode of presentation. PET may also be useful for preclinical detection and may supplement information from DNA studies.This publication has 13 references indexed in Scilit:
- A polymorphic DNA marker genetically linked to Huntington's diseaseNature, 1983
- Effects of Human Aging on Patterns of Local Cerebral Glucose Utilization Determined by the [18F] Fluorodeoxyglucose MethodJournal of Cerebral Blood Flow & Metabolism, 1982
- ALTERNATIVE FORMULA FOR GLUCOSE-UTILIZATION USING LABELED DEOXYGLUCOSE1982
- Huntington diseaseNeurology, 1981
- Noninvasive determination of local cerebral metabolic rate of glucose in manAmerican Journal of Physiology-Endocrinology and Metabolism, 1980
- Huntington diseaseNeurology, 1979
- Bicaudate index in computerized tomography of Huntington disease and cerebral atrophyNeurology, 1978
- Benign hereditary chorea Clinical and genetic aspectsClinical Genetics, 1978
- THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT1Journal of Neurochemistry, 1977
- Familial essential ("benign") chorea.Journal of Medical Genetics, 1976